Cargando…

The quality of life of comorbid patients with pathology of thyroid gland and gastroesophageal reflux disease

INTRODUCTION: In Russia, the prevalence of GERD is 18-46% [Ivashkin V. T., Maev I. V., Trukhmanov A. S., 2011]. GERD leads to a significant decrease in the quality of life of patients, especially with nocturnal symptoms, extraesophageal symptoms (chest pain, persistent cough), and increases the risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Artemieva, M., Manyakin, I., Basova, E., Ratenau, V. Fon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528206/
http://dx.doi.org/10.1192/j.eurpsy.2021.651
_version_ 1784801259299012608
author Artemieva, M.
Manyakin, I.
Basova, E.
Ratenau, V. Fon
author_facet Artemieva, M.
Manyakin, I.
Basova, E.
Ratenau, V. Fon
author_sort Artemieva, M.
collection PubMed
description INTRODUCTION: In Russia, the prevalence of GERD is 18-46% [Ivashkin V. T., Maev I. V., Trukhmanov A. S., 2011]. GERD leads to a significant decrease in the quality of life of patients, especially with nocturnal symptoms, extraesophageal symptoms (chest pain, persistent cough), and increases the risk of complications such as bleeding from ulcers and erosions, peptic strictures and, which causes the greatest caution, Barrett’s esophagus and esophageal adenocarcinomas OBJECTIVES: The medical and social significance of the pathology of the thyroid gland and gastrointestinal tract problem is determined by their high prevalence regardless of age, the annual increase in morbidity and the decrease in the quality of life (QOL). METHODS: Patients were divided in two groups: patients with GERD; patients with GERD and hypothyroidism. Quality of life was studied using the non-specific (general) SF 36 questionnaire. RESULTS: The lowest indicators were shown by patients with GERD and hypothyroidism (PF scale - Me 75.00 and 45.00 (p=0.005470), RF scale - 75,00 and 25.00 (p=0.043046), BP scale - 74.00 and 52.00 (p=0.036493), GH scale - 58.00 and 15.00 (p=0.009959)). The second group was more disadvantaged (VT scale - IU 52.50 and 32.50 (p=0.098125), SF scale - 75 00 and 50.00 (p=0.019016), RE scale - 33.30 and 0.00 (p=0.028841), GH scale - 48.00 and 36.00 (p=0.025919). CONCLUSIONS: According to the results, the presence of combined pathology of the thyroid gland and gastrointestinal tract significantly affected the physical and psychological component of health in the studied patients.
format Online
Article
Text
id pubmed-9528206
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-95282062022-10-17 The quality of life of comorbid patients with pathology of thyroid gland and gastroesophageal reflux disease Artemieva, M. Manyakin, I. Basova, E. Ratenau, V. Fon Eur Psychiatry Abstract INTRODUCTION: In Russia, the prevalence of GERD is 18-46% [Ivashkin V. T., Maev I. V., Trukhmanov A. S., 2011]. GERD leads to a significant decrease in the quality of life of patients, especially with nocturnal symptoms, extraesophageal symptoms (chest pain, persistent cough), and increases the risk of complications such as bleeding from ulcers and erosions, peptic strictures and, which causes the greatest caution, Barrett’s esophagus and esophageal adenocarcinomas OBJECTIVES: The medical and social significance of the pathology of the thyroid gland and gastrointestinal tract problem is determined by their high prevalence regardless of age, the annual increase in morbidity and the decrease in the quality of life (QOL). METHODS: Patients were divided in two groups: patients with GERD; patients with GERD and hypothyroidism. Quality of life was studied using the non-specific (general) SF 36 questionnaire. RESULTS: The lowest indicators were shown by patients with GERD and hypothyroidism (PF scale - Me 75.00 and 45.00 (p=0.005470), RF scale - 75,00 and 25.00 (p=0.043046), BP scale - 74.00 and 52.00 (p=0.036493), GH scale - 58.00 and 15.00 (p=0.009959)). The second group was more disadvantaged (VT scale - IU 52.50 and 32.50 (p=0.098125), SF scale - 75 00 and 50.00 (p=0.019016), RE scale - 33.30 and 0.00 (p=0.028841), GH scale - 48.00 and 36.00 (p=0.025919). CONCLUSIONS: According to the results, the presence of combined pathology of the thyroid gland and gastrointestinal tract significantly affected the physical and psychological component of health in the studied patients. Cambridge University Press 2021-08-13 /pmc/articles/PMC9528206/ http://dx.doi.org/10.1192/j.eurpsy.2021.651 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Artemieva, M.
Manyakin, I.
Basova, E.
Ratenau, V. Fon
The quality of life of comorbid patients with pathology of thyroid gland and gastroesophageal reflux disease
title The quality of life of comorbid patients with pathology of thyroid gland and gastroesophageal reflux disease
title_full The quality of life of comorbid patients with pathology of thyroid gland and gastroesophageal reflux disease
title_fullStr The quality of life of comorbid patients with pathology of thyroid gland and gastroesophageal reflux disease
title_full_unstemmed The quality of life of comorbid patients with pathology of thyroid gland and gastroesophageal reflux disease
title_short The quality of life of comorbid patients with pathology of thyroid gland and gastroesophageal reflux disease
title_sort quality of life of comorbid patients with pathology of thyroid gland and gastroesophageal reflux disease
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528206/
http://dx.doi.org/10.1192/j.eurpsy.2021.651
work_keys_str_mv AT artemievam thequalityoflifeofcomorbidpatientswithpathologyofthyroidglandandgastroesophagealrefluxdisease
AT manyakini thequalityoflifeofcomorbidpatientswithpathologyofthyroidglandandgastroesophagealrefluxdisease
AT basovae thequalityoflifeofcomorbidpatientswithpathologyofthyroidglandandgastroesophagealrefluxdisease
AT ratenauvfon thequalityoflifeofcomorbidpatientswithpathologyofthyroidglandandgastroesophagealrefluxdisease
AT artemievam qualityoflifeofcomorbidpatientswithpathologyofthyroidglandandgastroesophagealrefluxdisease
AT manyakini qualityoflifeofcomorbidpatientswithpathologyofthyroidglandandgastroesophagealrefluxdisease
AT basovae qualityoflifeofcomorbidpatientswithpathologyofthyroidglandandgastroesophagealrefluxdisease
AT ratenauvfon qualityoflifeofcomorbidpatientswithpathologyofthyroidglandandgastroesophagealrefluxdisease